Hydromorphone Hydrochloride Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Hydromorphone Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Nov 1, 2017. Reported reason: Other

Shortage details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
76045-121-11
Dosage Form
Injection
Presentation
Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11)
Initial Posting
Nov 1, 2017

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.